Related legislations
- Law no. 7/89/M, of 4 September – Establishing a Set of Regulations on Advertising Activity
- Decree-Law no. 58/90/M, of 19 September – Regulating the Practice of Pharmaceutical Professions and Activities
- Decree-Law no. 59/90/M, of 19 September – Establishing and Regulating the Registration of Pharmaceutical Products Used in Macao
- Decree-Law no. 20/91/M, of 25 March – Amendment to Certain Articles of Decree-Law no. 58/90/M of 19 September (The Practice of Pharmaceutical Professions and Activities)
- Decree-Law no. 53/94/M, of 14 November – Approving the Licensing Scheme and Operation Requirements for Premises Engaging in the Preparation and Trade of Traditional Chinese Medicine Products
- Decree-Law no. 30/95/M, of 10 July – Establishing the Legal Regime of Advertisement of Pharmaceutical Products
- Decree-Law no. 34/99/M, of 19 July – Regulations of the Trade and Legal Use of Narcotic Drugs and Psychotropic Substances
- Administrative Regulation no. 21/2003, of 21 July – Amendment to Decree-Law no. 58/90/M of 19 September, which regulates the practice of pharmaceutical professions and activities
- Law no. 17/2009 of 10 August – Prohibition of Illegal Production, Trafficking and Consumption of Narcotic Drugs and Psychotropic Substances
- Law no. 4/2014－Amendment to Law no.17/2009 (Prohibition of Illegal Production, Trafficking and Consumption of Narcotic Drugs and Psychotropic Substances)
- Law no. 22/2020－Amendment to Law no.17/2009 (Prohibition of Illegal Production, Trafficking and Consumption of Narcotic and Psychotropic Substances)
- Law no. 10/2021－Amendment to Law no.17/2009 (Prohibition of Illegal Production, Trafficking and Consumption of Narcotic and Psychotropic Substances)
- Law no. 7/2003 – Foreign Trade Law
- Law no. 3/2016 – Amendment to Law no. 7/2003, Foreign Trade Law
- Technical Instruction of the Health Bureau no. 02/2000 – Documents Required for Import Licensing of Pharmaceutical Products
- Technical Instruction of the Health Bureau no. 02/2001 – Regulations on the Import of Pharmaceutical Products Containing Bovine-Derived Substances
- Technical Instruction of the Health Bureau no. 01/2003 – Classification Criteria of Oral Preparations Containing Vitamins and/or Minerals
- Technical Instruction of the Health Bureau no. 01/2004 – Standard Microbial Limit in Propriety Chinese Medicine and Traditional Medicine
- Technical Instruction of the Health Bureau no. 03/2004 – Regulations on Wholesale Activities
- Technical Instruction of the Health Bureau no. 01/2005 – Labelling Requirements on the Packaging of Radiopharmaceutical Products
- Technical Instruction of the Health Bureau no. 02/2005 – Classification Criteria of Products Intended for Human Beings Containing Chinese Medicinal Materials and/or Natural Medicinal Ingredients
- Technical Instruction of the Health Bureau no. 03/2005 – Labelling Requirements on the Packaging of Western Medicines
- Technical Instruction of the Health Bureau no. 04/2005 - Labelling Requirements on the Packaging of Propriety Chinese Medicine and Traditional Medicine
- Chief Executive Dispatch no. 132/2001 – Regulation on the Import of Bezoar Antidotal Tablets (Niu Huang Chieh Tu Pien)
- Dispatch of Health Bureau Director no. 6/SS/2004 – Prohibition of the Manufacture, Import and Sale of the Chinese Herbs Caulis Aristolochiae Manshuriensis (Guanmutong), Radix Aristolochiae Fangchi (Guangfangji), Radix Aristolochiae (Qingmuxiang) and their Pharmaceutical Preparations
- Dispatch of Health Bureau Director no. 7/SS/2004 – List of Chinese Medicinal Materials Adopted in Macao SAR
- Chief Executive Dispatch no. 120/2005 – Regulations on the Production and Import of Drugs Containing Bovine-Derived Substances
- Dispatch of the Secretary for Social Affairs and Culture no. 70/2008 – Lists of Prescription Medicines and Hospital-Only Medicines
- Dispatch of Health Bureau Director no. 47/SS/2009 – Documents Required for Import Licensing of Human Blood Products
- Dispatch of Health Bureau Director no. 09/SS/2012 - Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) for Pharmaceutical Products
- Dispatch of Health Bureau Director no. 10/SS/2013 – Regarding the Content Limit of Heavy Metals and Toxic Elements in Traditional Medicines
- Dispatch of the Chief Executive no. 244/2015 - Prohibition of the Import of Any Pharmaceutical Products Containing Both Corticosteroids and Nonsteroidal Anti-Inflammatory Substances
- Dispatch of Health Bureau Director no. 04/SS/2016 – Technical Instruction Regarding the Documents Required for Import of New Drugs
- Chief Executive Dispatch no. 487/2016 – List of Goods Approved for Importation